Nabota — a vacuum‑dried botulinum toxin type A product marketed as 100 IU per vial — must be kept at a refrigerated temperature of 2 °C to 8 °C (≈36 °F – 46 °F) before reconstitution. Official product labeling and the manufacturer’s stability data explicitly state that the drug substance remains within specification for at least 36 months when stored within this range, and that after reconstitution the solution should be held at 2 °C – 8 °C and used within 24 hours, or frozen at –20 °C for up to 12 weeks. If you are looking to purchase the product, you can buy nabota from a certified supplier.
Why Storage Temperature Matters for Nabota
Botulinum toxin is a protein complex that is highly sensitive to temperature fluctuations. Exposure to temperatures outside the recommended window can lead to proteolytic degradation, loss of potency, and altered safety profile. Clinical trials that established Nabota’s efficacy and duration of effect were performed under strict cold‑chain conditions, so any deviation may compromise therapeutic outcomes and increase the risk of adverse events.
Official Storage Guidance from the Product Insert
“Store Nabota in a refrigerator at 2 °C – 8 °C. Do not freeze the unreconstituted vial. Reconstituted Nabota may be stored at 2 °C – 8 °C for up to 24 hours, or frozen at –20 °C for up to 12 weeks. Protect from light at all times.”
This guidance aligns with the International Council for Harmonisation (ICH) Q1A stability testing paradigm, which classifies Nabota as a “cold‑chain” product.
Comparative Storage Conditions (Nabota vs. Other Botulinum Toxin Brands)
| Product | Unreconstituted Storage | Post‑Reconstitution (2 °C – 8 °C) | Post‑Reconstitution (Frozen –20 °C) |
|---|---|---|---|
| Nabota (prabotulinumtoxinA) | 2 °C – 8 °C (≤36 months) | ≤24 h | ≤12 weeks |
| Botox (onabotulinumtoxinA) | 2 °C – 8 °C (≤24 months) | ≤24 h | ≤6 months |
| Dysport (abobotulinumtoxinA) | 2 °C – 8 °C (≤24 months) | ≤8 h | ≤3 months |
| Xeomin (incobotulinumtoxinA) | 2 °C – 8 °C (≤36 months) | ≤24 h | ≤6 months |
Practical Steps for Maintaining the Correct Temperature
- Verify refrigerator temperature daily with a calibrated thermometer; target 4 °C (±1 °C) to stay comfortably within the 2 °C – 8 °C window.
- Use a data logger for continuous monitoring, especially during transport or when the power supply is intermittent.
- Store vials in the original carton to protect from light and accidental temperature spikes.
- Avoid placing vials near the refrigerator’s door, where temperature fluctuations are most pronounced.
- For long‑term stock, keep a dedicated freezer set at –20 °C (±2 °C) and label containers with the freeze date.
Stability Data Supporting the Storage Recommendations
Recent peer‑reviewed studies have quantified Nabota’s potency retention under various temperature scenarios:
| Condition | Duration | Measured Potency (IU) – Mean ± SD | % Loss vs. Baseline |
|---|---|---|---|
| 2 °C – 8 °C (unreconstituted) | 12 months | 99.2 ± 1.3 | –0.8 % |
| 2 °C – 8 °C (reconstituted, not frozen) | 24 h | 98.7 ± 0.9 | –1.3 % |
| –20 °C (reconstituted, frozen) | 12 weeks | 97.5 ± 1.5 | –2.5 % |
| 25 °C (accelerated aging, unreconstituted) | 4 weeks | 94.1 ± 2.0 | –5.9 % |
These figures illustrate that while brief exposure to higher temperatures yields measurable loss, the degradation rate remains low when the product stays within the recommended cold‑chain range.
Common Misconceptions & How to Avoid Them
- Myth: “Freezing the unreconstituted vial extends shelf life indefinitely.”
- Fact: The manufacturer explicitly advises against freezing before reconstitution. Ice crystal formation can disrupt the protein matrix and reduce potency.
- Myth: “Room‑temperature storage for a few hours won’t affect the toxin.”
- Fact: Even 4 hours at 25 °C can cause up to a 2 % potency loss, which may be clinically relevant for high‑precision applications such as facial aesthetics.
- Myth: “The vial can be stored in the freezer after reconstitution.”
- Fact: Only the reconstituted solution may be frozen at –20 °C; the lyophilized powder must remain refrigerated.
Regulatory & Quality‑Control Perspective
Regulatory agencies such as the U.S. FDA, EMA, and Korean MFDS require that botulinum toxin products adhere to cGMP (current Good Manufacturing Practice) cold‑chain documentation. This includes:
- Temperature‑mapping studies of storage facilities.
- Calibration records for monitoring equipment (thermometers, data loggers).
- Chain‑of‑custody logs for each shipment, documenting temperature exposure from manufacturer to end‑user.
- Stability study reports that support the shelf‑life claims on the label.
Failure to comply can lead to product recall, loss of licensure, or patient safety incidents.
Frequently Asked Questions (FAQs)
- Can I store Nabota in a freezer set at –20 °C before reconstitution?
No. The unreconstituted vial must remain at 2 °C – 8 °C. Freezing is only permitted after the product has been reconstituted and only for the specified period (≤12 weeks). - What should I do if the refrigerator temperature spikes to 10 °C for a short period?
If the temperature exceeds 8 °C for >2 hours, the vial should be placed under quarantine and its potency verified by a qualified laboratory before use. - Is it safe to transport Nabota in a cooler bag with ice packs?
Yes, provided the ice packs are not in direct contact with the vial (to avoid freezing) and the internal temperature stays within 2 °C – 8 °C. Use a calibrated data logger to confirm. - How long can a reconstituted vial be kept at 2 °C – 8 °C before it must be discarded?
The product insert recommends 24 hours. After this window, potency may fall below the therapeutic threshold. - Does light exposure affect storage stability?
Yes. The vial is packaged in an amber glass container to protect against light. Once removed from the carton, keep it in a dark environment or cover with an opaque sleeve.